JohnRobertTicehurstMDFIDSA

PubMed

• 113 citations
  Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture.
  Jeffrey I. Cohen, John R. Ticehurst, S M Feinstone, B Rosenblum, Robert H. Purcell
  Journal of Virology. 1987-10-01
• 50 citations
  Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA.
  Jeffrey I. Cohen, B Rosenblum, S M Feinstone, John R. Ticehurst, Robert H. Purcell
  Journal of Virology. 1989-12-01
• 125 citations
  Epidemic Hepatitis E In Pakistan: Patterns Of Serologic Response And Evidence That Antibody To Hepatitis E Virus Protects Against Disease
  Joe P. Bryan, Sergei A. Tsarev, Mohammed Iqbal, John R. Ticehurst, Suzanne U. Emerson
  The Journal of Infectious Diseases. 1994-09-01

Journal Articles

• Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center  
  Sue PK, Pisanic N, Heaney CD, Forman M, Valsamakis A, Jackson AM, Ticehurst J, Montgomery RA, Schwarz KB, Nelson KE, Karnsakul W, Open Forum Infect Dis, 1/1/2016
• Two generations of "gold standards": the impact of a decade in hepatitis E virus testing innovation on population seroprevalence  
  Kmush BL, Labrique AB, Dalton HR, Ahmed ZB, Ticehurst J, Heaney CD, Nelson KB, Zaman K, Am J Trop Med Hyg, 1/1/2015
• Variability of hepatitis E serologic assays in a pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the United States  
  Sue PK, Pisanic N, Heaney CD, Mixson-Hayden T, Kamili S, Nelson K, Schwarz KB, Forman M, Valsamakis A, Ticehurst J, Karnsakul W, Transplant Infect Dis, 1/1/2015
• Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis  
  Ticehurst JR, Hamzeh F, Thomas DL, J Clin Microbiol, 1/1/2007
• Effective detection of toxigenic Clostridium difficile by using a two-step testing algorithm for antigen and cytotoxin  
  Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC, J Clin Microbiol, 1/1/2006
• NIST [National Institute of Standards & Technology] physical standards for DNA-based medical testing  
  Barker PE, Watson MS, Ticehurst JR, Colbert JC, O'Connell CD, J Clin Lab Analysis, 1/1/2002
• HIV seroconversion and evolution of the hepatitis C virus quasispecies  
  Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas DL, J Virol, 1/1/2001
• Non-A, B, or C hepatitis  
  Carpenter CF, Ticehurst JR, Curr Treatment Options in Infect Dis, 1/1/2000
• Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single- and double-stranded DNAs  
  Wang Y-M, Ray SC, Laeyendecker O, Ticehurst JR, Thomas DL, J Clin Microbiol, 1/1/1998
• Detection du virus de l'hepatite E par immunocapture et amplification genomique  
  Caudill J, van Cuyck-Gandre H, Zhang HY, Miele T, Ticehurst J, Longer CF, SSA Trav Scient, 1/1/1994
• Experimental hepatitis E: pathogenesis in cynomolgus macaques  
  Longer CF, Denny SL, Caudill JD, Miele TA, Asher LVS, Myint KSA, Huang CC, Engler WF, LeDuc JW, Binn LN, Ticehurst JR, J Infect Dis, 1/1/1993
• Initial report of a hepatitis investigation in rural Belize  
  Hoffman KJ, Gaydos JC, Krieg RE, Duncan JF Jr, MacArthy PO, Ticehurst JR, Jaramillo R, Reyes LG, Sjogren MH, Legters LJ, Proc Royal Soc Trop Med Hyg, 1/1/1993
• Detection of hepatitis A virus in sewage sludge by antigen-capture polymerase chain reaction  
  Graff J, Ticehurst JR, Flehmig B, Appl Environ Microbiol, 1/1/1993
• Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure & growth in cell culture with other HAV strains  
  Tsarev SA, Emerson SU, Balayan MS, Ticehurst J, Purcell RH, J Gen Virol, 1/1/1991
• Immunogenicity of an inactivated hepatitis A vaccine  
  Sjogren MH, Hoke CH, Binn LN, Eckels KH, Dubois DR, Lyde L, Tsuchida A, Oaks S, Marchwicki R, Ledner W, Chloupek R, Ticehurst J, Bancroft WH, Ann Intern Med, 1/1/1991
• Attenuation and cell culture adaptation of hepatitis A virus: a genetic analysis with hepatitis A virus cDNA  
  Cohen JI, Rosenblum B, Feinstone SM, Ticehurst J, Purcell RH, J Virol, 1/1/1989
• Aetiologic association of a virus like particle with enterically-transmitted non-A, non-B hepatitis  
  Arankalle VA, Ticehurst J, Sreenivasan MA, Kapikian AZ, Popper H, Pavri KM, Purcell RH, Lancet, 1/1/1988
• Detection of hepatitis B virus DNA in asymptomatic HBsAg carriers: relationship to sexual transmission  
  Tassopoulos NC, Roumeliotou-Karayannis A, Ticehurst J, Feinstone SM, Purcell RH, Papaevangelou G, Am J Epidemiol, 1/1/1987
• Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus  
  Cohen JI, Rosenblum B, Ticehurst JR, Daemer RJ, Feinstone SM, Purcell RH, Proc Natl Acad Sci USA, 1/1/1987
• Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of HAV and other picornaviruses  
  Cohen JI, Ticehurst JR, Purcell RH, Buckler-White A, Baroudy BM, J Virol, 1/1/1987
• Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase  
  Baroudy BM, Ticehurst JR, Miele TA, Maizel JV, Purcell RH, Feinstone SM, Proc Natl Acad Sci USA, 1/1/1985
• Molecular cloning and characterization of hepatitis A virus cDNA  
  Ticehurst JR, Racaniello VR, Baroudy BM, Baltimore D, Purcell RH, Feinstone SM, Proc Natl Acad Sci USA, 1/1/1983
• Join now to see all

Books/Book Chapters

• Enterically-Transmitted Hepatitis Viruses 
  Chapter: Observations on subclinical hepatitis E virus infection and protection against reinfection. 
  Page 362 - 372Longer CF, Elliott JE, Caudill JD, Binn LB, Bryan JP, Iqbal M, Innis BL, Clayson ET, Shrestha MP, Tsarev SA, Zhang HY, Ticehurst JEditors: Buisson Y, Coursaget P, Kane M.La Simarre, Joue-les-Tours, France1996
• Manual of Clinical Microbiology 
  Chapter: Hepatitis E virus. 
  Page 1056 - 1067Ticehurst JEditors: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH.American Society for Microbiology, WashingtonEdition 6th,1995
• Viral Hepatitis & Liver Disease 
  Chapter: Epidemiology of hepatitis E virus: a cohort study in Kathmandu, Nepal. 
  Page 409 - 411Longer CF, Shrestha MP, MacArthy PO, Myint KSA, Hoke CH Jr, Ticehurst J, Innis BLEditors: Nishioka K, Suzuki H, Mishiro S, Oda T.Springer-Verlag, Tokyo1994
• Immunology of Liver Disease 
  Chapter: Immunopathology of hepatitis A and hepatitis E infections. 
  Page 11 - 37Brown EA, Ticehurst JR, Lemon SMEditors: Thomas HC, Waters J.Kluwer Academic, Lancaster, UK1994
• Contamination of the Environment by Viruses and Methods of Control 
  Chapter: Detection of hepatitis A virus in sludge by blot hybridization and cell culture. 
  Page 1 - 4Graff J, Dotzauer A, Ticehurst JR, Vallbracht A, Flehmig BEditors: Farrah SR, Walter R.Weiner Metteilungen, Vienna1993
• Viral Hepatitis and Liver Disease 
  Chapter: Identification and characterization of hepatitis E virus. 
  Page 501 - 513Ticehurst JEditors: Hollinger FB, Lemon SM, Margolis HS.Williams & Wilkins, Baltimore1991
• Fields Virology 
  Chapter: Hepatitis A virus. 
  Page 631 - 667Hollinger FB, Ticehurst JEditors: Fields BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP, Roizman B.Raven, New YorkEdition 2nd,1990
• Molecular Aspects of Picornavirus Infection and Detection 
  Chapter: Replication of hepatitis A virus: new ideas from studies with cloned cDNA. 
  Page 27 - 50Ticehurst J, Cohen JI, Feinstone SM, Purcell RH, Jansen RW, Lemon SMEditors: Semler BL, Ehrenfeld E.American Society for Microbiology, Washington1989
• Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections 
  Chapter: Viral hepatitis. 
  Page 957 - 1065Purcell R, Hoofnagle JH, Ticehurst JR, Gerin JLEditors: Schmidt NJ, Emmons RW.American Society for Microbiology, Washington1989
• Viral Hepatitis & Liver Disease 
  Chapter: Analyses of molecular sequences demonstrate that hepatitis A virus is a unique picornavirus. 
  Page 33 - 35Ticehurst J, Cohen JI, Purcell RHEditors: Zuckerman AJ.AR Liss1988
• Viral Hepatitis and Liver Disease 
  Chapter: Enterically transmitted non-A, non-B hepatitis: epidemiology and clinical characteristics. 
  Page 131 - 137Purcell RH, Ticehurst JREditors: Zuckerman AJ.AR Liss, NY1988
• Viral Infection 
  Chapter: Development of hepatitis A vaccines. 
  Page 82 - 86Ticehurst JR, Karron R, Daemer R, Cohen JI, Baroudy BM, Feinstone SM, Purcell RHEditors: Marget W, Lang W, Gabler-Sandberger E.MM Medizin Verlag, Munchen1986
• Viral Hepatitis & Liver Disease 
  Chapter: Hepatitis A virus. 
  Page 9 - 22Purcell RH, Feinstone SM, Ticehurst JR, Daemer RJ, Baroudy BMEditors: Vyas GN, Dienstag JL, Hoofnagle JH.Grune & Stratton, Orlando1984
• Modern Approaches to Vaccines: Molecular & Chemical Basis of Virus Virulence &Immunogenicity 
  Chapter: Approaches to the development of hepatitis A vaccines: the old and the new. 
  Page 59 - 63Purcell RH, Feinstone SM, Daemer RJ, Ticehurst JR, Baroudy BMEditors: Chanock RM, Lerner RA.Cold Spring Harbor Laboratory, NY1984
• Join now to see all

Abstracts/Posters

• Shigella sonnei colicin- and Type VI Secretion System-mediated killing: characterization and vaccine impact.
  North M, Ticehurst J, Barnoy S, Venkatesan M, World Vaccine Congress, Washington, 1/1/2018
• Hepatitis E Virus (HEV) is elusive in a frequently sampled, 'non-endemic' population with 17% IgG anti-HEV reactivity.
  Engle RE, Forman MS, Thomas DL, Purcell RH, Ticehurst JR, XIII International Symposium on Viral Hepatitis & Liver Disease, Washington, 1/1/2009
• Detection of human rhinoviruses by real time PCR.
  Forman MS, Clemens SH, Gluck LL, Ticehurst J, Valsamakis A, 27th Clinical Virology Symposium & Annual Meeting of the Pan American Society for Clinical Virology, Daytona Beach, FL, 1/1/2008
• Development of novel real-time polymerase chain reaction assays for the detection of aerosolized Yersinia rohdei in the presence of common clutters.
  Cunningham D, Proescher A, Hahn J, Ticehurst J, Quizon R, Young C, 6th ASM Biodefense & Emerging Diseases Research Meeting, Baltimore, 1/1/2008
• Join now to see all

Lectures

• A Marylander with hepatitis E virus, genotype 3. 
  Clearwater Beach, FL - 1/1/2007
• Biothreat-preparedness. 
  Catonsville, MD - 1/1/2001
• Hepatitis C virus. 
  Charlotte, NC - 1/1/2000
• Premarket Approval Applications for 'COBAS AMPLICOR' & 'AMPLICOR' (Roche Molecular Systems) qualitative PCR-based assays for hepatitis C virus RNA. 
  1/1/2000
• Clinical studies in the Premarket Approval Application for 'AxSYM anti-HCV' (Abbott Laboratories) enzyme immunoassay for IgG antibodies to hepatitis C virus. 
  1/1/2000
• Evidence-based clinical virology. 
  Clearwater Beach, FL - 1/1/2000
• "Significance of a history of having had hepatitis A or E." 
  1/1/1999
• Studies to determine appropriate use of PCR-based assays. 
  Alexandria, VA - 1/1/1998
• Clinical uses of assays for evidence of infection with hepatitis viruses A, B, or C. 
  1/1/1998
• Assays for Borrelia burgdorferi. 
  Cold Spring Harbor, NY - 1/1/1997
• PCR for clinical labs. 
  Baltimore - 1/1/1997
• Clinical performance of assays for antibodies to Borrelia burgdorferi. 
  1/1/1996
• Hepatitis viruses A, B, C, D, & E. 
  Baltimore - 1/1/1994
• HEV: seroepidemiology & detection of infection. 
  Chicago - 1/1/1991
• Hepatitis E virus. 
  Houston - 1/1/1990
• Hepatitis viruses A & E. 
  Moscow - 1/1/1988
• Hepatitis A virus. 
  London - 1/1/1986
• Join now to see all

Other

• Applied Sequencing Center initiative. 
  Feldman A, Demirev P, Greenberg A, Lin J, Mehoke T, Van Gieson E, Young C, Hahn J, Proescher J, Quizon R, Sivakumar A, Ticehurst J, Chakravarti A, Schwab K, Kumar N, Johns Hopkins APL Technical Digest
  1/1/2010
• Change in rapid testing for respiratory viruses. 
  Judson K, Ticehurst J, JHBMC Clinical Laboratories
  1/1/2006
• Information about changes in rapid anti-HIV testing. 
  Georgy M, Maters A, Ticehurst J, Carroll K, JHBMC Clinical Laboratories & JHH Medical Microbiology
  1/1/2005
• West Nile virus laboratory-testing guidelines. 
  Swierczynski S, Ticehurst J, JHBMC Clinical Laboratories
  1/1/2003
• Mislabeled or unidentified patient specimens. 
  Ticehurst JR, Policy L11, JHBMC Patient Care Practices Manual
  1/1/2003
• Clinical anthrax: primer for physicians. 
  Bartlett JG, Ticehurst J, Zenilman J, Borio L, Charache P, Martins C, Inglesby T, hopkins-biodefense.org
  1/1/2001
• Premarket approval applications for in vitro diagnostic devices pertaining to hepatitis C viruses (HCV): assays intended for diagnosis, prognosis, or monitoring of HCV... 
  Ticehurst J, Wright K, CDRH (Center for Devices and Radiological Health)
  web.archive.org/web/20030405154523/http://www.fda.gov/OHRMS/DOCKETS/98fr/993028gd.pdf
  1/1/1999
• FDA Public Health Advisory: Assays for antibodies to Borrelia burgdorferi; limitations, use, & interpretation for supporting a clinical diagnosis of Lyme disease. 
  Burlington DB, Hansen S, Ticehurst J
  wayback.archive-it.org/7993/20170111190742/http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062429.htm
  Washington, DC - 1/1/1997
• Join now to see all